Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Mark Abzug

Concepts (408)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enterovirus Infections
21
2019
177
2.760
 Why?
HIV Infections
27
2022
2836
1.810
 Why?
Antiretroviral Therapy, Highly Active
9
2017
271
1.690
 Why?
Pneumococcal Vaccines
5
2021
142
1.620
 Why?
Antiviral Agents
12
2024
744
1.450
 Why?
Pregnancy Complications, Infectious
14
2015
394
1.370
 Why?
Enterovirus
9
2019
86
1.180
 Why?
Hematopoietic Stem Cell Transplantation
4
2021
622
0.990
 Why?
Immunologic Memory
3
2013
353
0.940
 Why?
Pneumococcal Infections
3
2013
115
0.900
 Why?
Immunization, Secondary
4
2021
87
0.900
 Why?
Oxadiazoles
4
2015
33
0.830
 Why?
Paralysis
4
2018
71
0.720
 Why?
Child
56
2024
21935
0.660
 Why?
Triazoles
3
2024
147
0.630
 Why?
Sinusitis
7
2013
221
0.580
 Why?
Mucositis
1
2018
19
0.580
 Why?
Anti-Retroviral Agents
8
2022
233
0.580
 Why?
Vaccination
4
2017
1381
0.570
 Why?
Meningoencephalitis
1
2017
25
0.560
 Why?
Candidiasis, Invasive
3
2024
6
0.550
 Why?
Antibodies, Bacterial
4
2013
146
0.540
 Why?
Myelitis
4
2019
107
0.530
 Why?
Influenza, Human
5
2015
622
0.530
 Why?
Theilovirus
4
2000
4
0.520
 Why?
Influenza A Virus, H1N1 Subtype
3
2015
148
0.490
 Why?
Encephalitis
1
2017
136
0.490
 Why?
Graft vs Host Disease
1
2018
252
0.490
 Why?
Encephalomyelitis, Acute Disseminated
1
2015
11
0.470
 Why?
Neonatal Sepsis
1
2015
4
0.470
 Why?
Immunocompromised Host
5
2021
202
0.460
 Why?
Central Nervous System Viral Diseases
4
2019
79
0.460
 Why?
Herpes Simplex
4
2017
95
0.460
 Why?
Antifungal Agents
5
2024
136
0.450
 Why?
Influenza Vaccines
3
2015
539
0.450
 Why?
Disease Outbreaks
6
2019
395
0.430
 Why?
Neuromyelitis Optica
1
2015
132
0.410
 Why?
CD4 Lymphocyte Count
8
2022
269
0.410
 Why?
Placenta
6
2000
750
0.410
 Why?
Child, Preschool
28
2024
11074
0.400
 Why?
Adolescent
37
2024
21513
0.400
 Why?
Humans
89
2024
137585
0.400
 Why?
Infant
27
2024
9465
0.390
 Why?
Infant, Newborn
25
2018
6079
0.390
 Why?
Neuromuscular Diseases
3
2019
132
0.390
 Why?
Drug Discovery
1
2013
142
0.390
 Why?
Measles Vaccine
1
2012
21
0.390
 Why?
Mucormycosis
3
2005
22
0.380
 Why?
RNA, Viral
12
2013
656
0.360
 Why?
Female
62
2024
73304
0.350
 Why?
Male
53
2024
67762
0.350
 Why?
Cardiovirus Infections
2
2000
2
0.340
 Why?
Meningococcal Vaccines
2
2012
55
0.340
 Why?
Anti-HIV Agents
5
2022
778
0.340
 Why?
Viral Vaccines
2
2009
98
0.330
 Why?
Candidemia
2
2023
11
0.330
 Why?
Oxazoles
4
2015
37
0.330
 Why?
Viral Load
7
2017
466
0.320
 Why?
Hepatitis B Vaccines
1
2009
45
0.310
 Why?
AIDS-Related Opportunistic Infections
3
2015
127
0.310
 Why?
Bacterial Vaccines
1
2009
63
0.300
 Why?
Fatigue Syndrome, Chronic
1
2008
17
0.280
 Why?
Pertussis Vaccine
1
2007
22
0.280
 Why?
Communicable Diseases, Emerging
1
2008
36
0.280
 Why?
Poliomyelitis
2
1997
37
0.270
 Why?
Mycetoma
2
2004
6
0.260
 Why?
Immunoglobulins, Intravenous
3
1997
132
0.260
 Why?
Viremia
5
2021
138
0.260
 Why?
Rhinitis
3
2009
158
0.250
 Why?
Fetus
3
2000
806
0.250
 Why?
Pregnancy
16
2021
6763
0.220
 Why?
Antibodies, Viral
5
2022
625
0.220
 Why?
Enterovirus B, Human
3
2001
26
0.220
 Why?
Meningitis, Viral
2
2004
21
0.220
 Why?
Anti-Bacterial Agents
3
2013
1809
0.220
 Why?
Maxillary Sinusitis
2
2004
7
0.220
 Why?
Maus Elberfeld virus
3
1993
5
0.210
 Why?
Cytomegalovirus
2
2016
157
0.210
 Why?
Interferon-gamma
2
2015
789
0.200
 Why?
Acquired Immunodeficiency Syndrome
2
2017
230
0.200
 Why?
Global Health
2
2018
386
0.200
 Why?
Placenta Diseases
2
1995
18
0.190
 Why?
Administration, Intravenous
2
2024
155
0.190
 Why?
Centralized Hospital Services
1
2001
6
0.190
 Why?
Pneumonia, Viral
2
2021
373
0.180
 Why?
Fetal Diseases
3
2000
173
0.180
 Why?
Oseltamivir
2
2012
12
0.180
 Why?
Hepatitis, Viral, Human
1
2001
25
0.180
 Why?
Research Support as Topic
1
2001
119
0.170
 Why?
Colorado
7
2021
4565
0.170
 Why?
United States
13
2021
14841
0.170
 Why?
Retrospective Studies
14
2022
15657
0.160
 Why?
Ethmoid Sinusitis
1
1999
2
0.160
 Why?
Streptococcus pneumoniae
3
2014
169
0.160
 Why?
Hydrops Fetalis
1
1999
13
0.160
 Why?
Intracranial Hemorrhages
1
2000
85
0.160
 Why?
Uterine Diseases
1
1999
15
0.160
 Why?
Blood Coagulation Disorders
1
2001
173
0.160
 Why?
Embryonic Development
1
2000
119
0.150
 Why?
Polymerase Chain Reaction
4
2016
1062
0.150
 Why?
Drug Resistance, Microbial
1
1999
71
0.150
 Why?
Treatment Outcome
10
2024
10811
0.150
 Why?
Young Adult
14
2017
13209
0.150
 Why?
Mastoiditis
2
2014
5
0.150
 Why?
Follow-Up Studies
8
2022
5131
0.150
 Why?
Biliary Atresia
1
2020
163
0.150
 Why?
Neurodevelopmental Disorders
1
2021
181
0.150
 Why?
Nervous System Diseases
2
2019
266
0.150
 Why?
Risk Factors
12
2024
10388
0.150
 Why?
Fluoxetine
1
2018
54
0.140
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
2
2009
13
0.140
 Why?
Enterovirus D, Human
2
2018
85
0.140
 Why?
Hospitals, Pediatric
1
2001
508
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
852
0.140
 Why?
Arboviruses
1
2017
16
0.140
 Why?
Nucleic Acid Hybridization
6
1991
190
0.140
 Why?
Double-Blind Method
3
2015
1993
0.140
 Why?
In Situ Hybridization
4
2000
316
0.140
 Why?
Disease Transmission, Infectious
1
2018
62
0.140
 Why?
HIV-1
2
2015
864
0.140
 Why?
Allografts
1
2018
146
0.140
 Why?
Acyclovir
2
2015
101
0.140
 Why?
Antibodies, Monoclonal
2
2022
1430
0.140
 Why?
Cohort Studies
7
2024
5742
0.130
 Why?
Sexual Maturation
1
2017
55
0.130
 Why?
Immunization, Passive
1
1997
90
0.130
 Why?
Endoscopy
1
1999
318
0.130
 Why?
Brain
3
2017
2668
0.130
 Why?
Practice Guidelines as Topic
2
2022
1587
0.130
 Why?
Clinical Trials as Topic
1
2001
1050
0.130
 Why?
Cytomegalovirus Retinitis
1
2016
21
0.130
 Why?
Postoperative Complications
2
2016
2654
0.120
 Why?
Adoption
1
2016
32
0.120
 Why?
Hyperlipidemias
1
2017
120
0.120
 Why?
Nasal Mucosa
2
2009
107
0.120
 Why?
DNA, Viral
2
2016
364
0.120
 Why?
Gastrointestinal Diseases
1
2018
209
0.120
 Why?
Mice, Inbred ICR
4
1997
119
0.120
 Why?
Diagnosis, Differential
2
2017
1483
0.120
 Why?
Congenital Abnormalities
2
2010
92
0.120
 Why?
Antibodies, Neutralizing
2
2022
286
0.120
 Why?
Sexually Transmitted Diseases
1
2017
161
0.120
 Why?
Respiratory Syncytial Virus Infections
1
1997
128
0.120
 Why?
Lymphocyte Subsets
1
2015
87
0.120
 Why?
Ganciclovir
1
2015
53
0.120
 Why?
Child Development
2
2017
475
0.120
 Why?
Chi-Square Distribution
2
2013
530
0.120
 Why?
Muscle Hypotonia
1
2015
33
0.120
 Why?
Oropharynx
1
2015
46
0.120
 Why?
Lymphopenia
1
2015
62
0.110
 Why?
Adult
17
2022
37929
0.110
 Why?
Cranial Nerve Diseases
1
2015
42
0.110
 Why?
Adenovirus Infections, Human
2
1991
15
0.110
 Why?
Incidence
6
2017
2804
0.110
 Why?
Hearing Loss, Sensorineural
1
2015
67
0.110
 Why?
Controlled Clinical Trials as Topic
1
2013
30
0.110
 Why?
Beclomethasone
1
1993
27
0.110
 Why?
Puberty, Delayed
1
2013
9
0.110
 Why?
Mycoses
1
2014
79
0.110
 Why?
Rectum
1
2015
185
0.100
 Why?
Antibody Affinity
1
2013
60
0.100
 Why?
Cytomegalovirus Infections
1
2015
192
0.100
 Why?
Giant Cells
1
1993
24
0.100
 Why?
Hemagglutination Inhibition Tests
1
2013
38
0.100
 Why?
Intensive Care Units, Pediatric
1
2015
233
0.100
 Why?
Chickenpox
1
1993
83
0.100
 Why?
Candida
1
2012
38
0.100
 Why?
Liver Transplantation
1
2020
871
0.100
 Why?
Viral Plaque Assay
1
2012
31
0.100
 Why?
Orthomyxoviridae
1
2012
40
0.100
 Why?
Hospital Design and Construction
1
1992
5
0.100
 Why?
Neutralization Tests
1
2012
75
0.100
 Why?
Aircraft
1
1992
22
0.100
 Why?
CD4-Positive T-Lymphocytes
2
2017
1091
0.100
 Why?
HIV
1
2013
234
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
Bacterial Infections
2
2009
250
0.090
 Why?
Drug Resistance, Viral
1
2012
116
0.090
 Why?
Severity of Illness Index
4
2021
2828
0.090
 Why?
Chlamydia trachomatis
1
1991
49
0.090
 Why?
Gestational Age
4
2015
910
0.090
 Why?
Chorioamnionitis
1
1991
42
0.090
 Why?
Decision Support Techniques
1
2015
421
0.090
 Why?
Peritoneovenous Shunt
1
1990
1
0.090
 Why?
Maternal-Fetal Exchange
2
2007
165
0.090
 Why?
Trophoblasts
1
1993
199
0.090
 Why?
Meningitis, Aseptic
1
1990
13
0.090
 Why?
Prospective Studies
7
2017
7604
0.080
 Why?
Poliovirus Vaccine, Oral
1
1990
25
0.080
 Why?
Rimantadine
1
2010
1
0.080
 Why?
Legionnaires' Disease
1
1990
4
0.080
 Why?
Adamantane
1
2010
18
0.080
 Why?
Poliovirus
1
1990
85
0.080
 Why?
Biomarkers
1
2021
4149
0.080
 Why?
Hepatitis B Antibodies
1
2009
11
0.080
 Why?
Cross Infection
1
1992
256
0.080
 Why?
Meningitis
1
1990
79
0.080
 Why?
Administration, Oral
3
2012
816
0.080
 Why?
Respiratory Tract Infections
3
2016
390
0.080
 Why?
T-Lymphocytes
2
2015
1996
0.080
 Why?
Maxillary Sinus
2
2009
11
0.070
 Why?
Mice
8
2000
17787
0.070
 Why?
South Africa
1
2009
222
0.070
 Why?
Age Factors
4
2017
3295
0.070
 Why?
Mucor
2
2005
7
0.070
 Why?
Body Fluids
1
1987
66
0.070
 Why?
Drug Administration Schedule
2
2015
786
0.070
 Why?
Evidence-Based Medicine
3
2021
740
0.070
 Why?
Acute Kidney Injury
1
2015
815
0.070
 Why?
Aspergillosis
2
2014
21
0.070
 Why?
Reverse Transcriptase Inhibitors
1
2007
84
0.070
 Why?
Virus Diseases
1
2009
212
0.060
 Why?
Mitochondrial Diseases
1
2007
91
0.060
 Why?
Zygomycosis
1
2006
6
0.060
 Why?
Antibodies, Monoclonal, Humanized
2
2022
804
0.060
 Why?
Carotid Artery Thrombosis
1
2005
7
0.060
 Why?
Organ Transplantation
1
2009
250
0.060
 Why?
Statistics as Topic
1
2006
307
0.060
 Why?
Chronic Disease
5
2009
1793
0.060
 Why?
Logistic Models
2
2023
2074
0.060
 Why?
Drug Therapy, Combination
2
2007
1066
0.060
 Why?
International Cooperation
2
2018
198
0.060
 Why?
Scedosporium
1
2004
1
0.060
 Why?
Herpesvirus 7, Human
1
2004
6
0.060
 Why?
Drug Resistance, Fungal
1
2004
7
0.060
 Why?
Roseolovirus Infections
1
2004
8
0.060
 Why?
Longitudinal Studies
3
2018
2844
0.060
 Why?
Randomized Controlled Trials as Topic
2
2004
1477
0.060
 Why?
Animals
9
2000
36940
0.060
 Why?
Herpesvirus 6, Human
1
2004
14
0.060
 Why?
Granulocyte Colony-Stimulating Factor
1
2004
74
0.060
 Why?
Respiratory Syncytial Viruses
2
1997
54
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2004
152
0.050
 Why?
Vaccines, Conjugate
2
2014
65
0.050
 Why?
Infant, Premature, Diseases
2
1997
101
0.050
 Why?
Biological Availability
1
2003
148
0.050
 Why?
Risk Assessment
2
2020
3457
0.050
 Why?
Probability
1
2003
304
0.050
 Why?
Growth Disorders
1
2022
86
0.050
 Why?
Reference Values
1
2003
816
0.040
 Why?
Bacteria, Aerobic
1
2001
7
0.040
 Why?
Case-Control Studies
3
2015
3556
0.040
 Why?
Disease Models, Animal
3
2000
4295
0.040
 Why?
Drug Combinations
1
2022
343
0.040
 Why?
Personnel Staffing and Scheduling
1
2001
96
0.040
 Why?
Income
1
2022
202
0.040
 Why?
Drug Approval
1
2021
88
0.040
 Why?
Adenosine Monophosphate
1
2021
66
0.040
 Why?
Prenatal Exposure Delayed Effects
1
2007
605
0.040
 Why?
RNA Probes
2
1991
13
0.040
 Why?
Disseminated Intravascular Coagulation
1
2000
35
0.040
 Why?
Systemic Inflammatory Response Syndrome
1
2021
93
0.040
 Why?
Alanine
1
2021
152
0.040
 Why?
United States Food and Drug Administration
1
2021
208
0.040
 Why?
RNA
2
2022
921
0.040
 Why?
Necrosis
1
2000
246
0.040
 Why?
Picornaviridae Infections
2
1990
47
0.040
 Why?
Remission Induction
1
2020
288
0.040
 Why?
Otitis Media with Effusion
1
1999
20
0.040
 Why?
Fungi
2
2014
144
0.040
 Why?
Cerebrospinal Fluid
2
2004
92
0.040
 Why?
Pharyngitis
1
1999
26
0.040
 Why?
Amniotic Fluid
2
1991
96
0.040
 Why?
Pseudallescheria
1
1999
3
0.040
 Why?
Zidovudine
2
2010
78
0.040
 Why?
Opportunistic Infections
1
1999
46
0.040
 Why?
Time Factors
1
2009
6828
0.040
 Why?
Dose-Response Relationship, Drug
1
2003
2057
0.040
 Why?
Diabetes Mellitus, Type 1
2
2005
3715
0.040
 Why?
Living Donors
1
2020
295
0.040
 Why?
Spinal Cord
1
2000
370
0.040
 Why?
Chlamydiaceae Infections
1
2017
1
0.040
 Why?
Epidemiological Monitoring
1
2018
60
0.030
 Why?
Nutrition Disorders
1
1997
23
0.030
 Why?
Internationality
1
2018
155
0.030
 Why?
Sex Factors
2
2017
2071
0.030
 Why?
Abortion, Spontaneous
1
1997
105
0.030
 Why?
B-Lymphocytes
2
2015
847
0.030
 Why?
Reoperation
1
1999
573
0.030
 Why?
Ophthalmoscopy
1
2016
36
0.030
 Why?
Antigens, Viral
1
2017
178
0.030
 Why?
Otitis Media
1
1999
165
0.030
 Why?
Heart
1
2000
655
0.030
 Why?
Encephalomyelitis
1
2016
12
0.030
 Why?
Plasma Cells
2
2009
71
0.030
 Why?
Tissue and Organ Procurement
1
2020
321
0.030
 Why?
Acute Disease
1
1999
1007
0.030
 Why?
Multicenter Studies as Topic
1
1997
310
0.030
 Why?
Enzyme-Linked Immunospot Assay
1
2015
36
0.030
 Why?
Immune Tolerance
2
1999
363
0.030
 Why?
AIDS Dementia Complex
1
2015
51
0.030
 Why?
Caribbean Region
1
2015
28
0.030
 Why?
Transplantation, Homologous
1
2016
416
0.030
 Why?
Molecular Diagnostic Techniques
1
2016
105
0.030
 Why?
North America
1
2016
313
0.030
 Why?
Encephalitis, Varicella Zoster
1
2015
17
0.030
 Why?
Encephalitis, Herpes Simplex
1
2015
21
0.030
 Why?
Audiometry
1
2015
29
0.030
 Why?
Patient Outcome Assessment
1
2016
131
0.030
 Why?
Malnutrition
1
2016
83
0.030
 Why?
Latin America
1
2015
93
0.030
 Why?
Evaluation Studies as Topic
1
1995
180
0.030
 Why?
Biopsy
3
2009
1129
0.030
 Why?
Physical Conditioning, Animal
1
1997
257
0.030
 Why?
Coinfection
1
2016
137
0.030
 Why?
Odds Ratio
1
2017
1070
0.030
 Why?
Hematologic Neoplasms
1
2016
156
0.030
 Why?
Microscopy, Electron
1
1995
443
0.030
 Why?
C-Reactive Protein
1
2017
410
0.030
 Why?
Evoked Potentials, Auditory, Brain Stem
1
2015
50
0.030
 Why?
Canada
1
2015
418
0.030
 Why?
Combined Modality Therapy
3
2005
1236
0.030
 Why?
Metabolic Diseases
1
2015
108
0.030
 Why?
Neutropenia
1
2015
146
0.030
 Why?
Papillomavirus Vaccines
1
2017
238
0.030
 Why?
Infusions, Intravenous
1
2015
413
0.030
 Why?
Multivariate Analysis
1
2017
1509
0.030
 Why?
Administration, Intranasal
1
1993
90
0.030
 Why?
Papillomavirus Infections
1
2017
325
0.030
 Why?
Sexual Behavior
1
2017
485
0.030
 Why?
Sequence Analysis, DNA
1
2016
812
0.030
 Why?
Mortality
1
2015
362
0.020
 Why?
Prognosis
1
2001
4030
0.020
 Why?
Epidemiologic Studies
1
2012
72
0.020
 Why?
T-Lymphocyte Subsets
1
2015
417
0.020
 Why?
Electromyography
1
2015
400
0.020
 Why?
Infant, Premature
1
1997
574
0.020
 Why?
Oncology Service, Hospital
1
1992
16
0.020
 Why?
Pandemics
1
2021
1639
0.020
 Why?
Neisseria meningitidis
1
2012
23
0.020
 Why?
Tomography, X-Ray Computed
2
1999
2691
0.020
 Why?
Meningococcal Infections
1
2012
25
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Ventilation
1
1992
44
0.020
 Why?
Amniocentesis
1
1991
25
0.020
 Why?
Mycoplasma Infections
1
1991
16
0.020
 Why?
Microbial Viability
1
2012
91
0.020
 Why?
Europe
1
2012
414
0.020
 Why?
Flow Cytometry
1
2015
1178
0.020
 Why?
Adenoviruses, Human
1
1991
27
0.020
 Why?
Aged, 80 and over
1
2023
7635
0.020
 Why?
Hospitals, University
1
1991
182
0.020
 Why?
Respirovirus Infections
1
1990
13
0.020
 Why?
Comorbidity
1
2016
1622
0.020
 Why?
Paramyxoviridae Infections
1
1990
13
0.020
 Why?
Lymphocyte Activation
1
2015
1142
0.020
 Why?
Anti-Infective Agents
1
2013
255
0.020
 Why?
Chlamydia Infections
1
1991
75
0.020
 Why?
Immunohistochemistry
1
1995
1738
0.020
 Why?
Benzoxazines
1
2010
31
0.020
 Why?
Rhinovirus
1
1990
58
0.020
 Why?
Cyclopropanes
1
2010
90
0.020
 Why?
Alkynes
1
2010
56
0.020
 Why?
Legionella
1
1990
7
0.020
 Why?
Sensitivity and Specificity
1
1995
1946
0.020
 Why?
Population Surveillance
1
1993
482
0.020
 Why?
Cells, Cultured
1
1997
4193
0.020
 Why?
Leukemia
1
1992
240
0.020
 Why?
Inpatients
1
2014
500
0.020
 Why?
Dermatomyositis
1
1989
27
0.020
 Why?
Hospitals
1
2014
691
0.020
 Why?
Magnetic Resonance Imaging
2
2015
3566
0.020
 Why?
Staining and Labeling
1
2009
150
0.020
 Why?
Peroxidase
1
2009
175
0.020
 Why?
Natural Killer T-Cells
1
2009
67
0.020
 Why?
Muscles
1
1989
326
0.020
 Why?
Respiratory Tract Diseases
1
1990
184
0.020
 Why?
Picornaviridae
1
1988
18
0.020
 Why?
Seasons
1
1990
547
0.020
 Why?
Central Nervous System
1
2010
258
0.020
 Why?
Ribonucleases
1
1987
55
0.020
 Why?
HIV Reverse Transcriptase
1
2007
31
0.020
 Why?
Lamivudine
1
2007
63
0.020
 Why?
Telencephalon
1
2005
16
0.020
 Why?
Cavernous Sinus
1
2005
19
0.020
 Why?
Antigens, CD
1
2009
521
0.020
 Why?
Infectious Disease Transmission, Vertical
1
2007
184
0.010
 Why?
Cross-Sectional Studies
1
2016
5472
0.010
 Why?
Orbit
1
2005
70
0.010
 Why?
Paranasal Sinuses
1
2005
80
0.010
 Why?
Exocrine Glands
1
2004
5
0.010
 Why?
Basement Membrane
1
2004
35
0.010
 Why?
Prevalence
1
2010
2734
0.010
 Why?
Cell Count
1
2004
324
0.010
 Why?
Neutrophils
1
2009
1238
0.010
 Why?
Lymphocytes
1
2004
397
0.010
 Why?
Penicillin Resistance
1
2001
8
0.010
 Why?
Eosinophils
1
2004
332
0.010
 Why?
Macrophages
1
2009
1547
0.010
 Why?
beta-Lactamases
1
2001
48
0.010
 Why?
Staphylococcus
1
2001
76
0.010
 Why?
Drug Resistance, Multiple, Bacterial
1
2001
78
0.010
 Why?
Haemophilus influenzae
1
2001
63
0.010
 Why?
Drug Resistance, Bacterial
1
2001
186
0.010
 Why?
Nasal Decongestants
1
1999
8
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
40
0.010
 Why?
Steroids
1
1999
167
0.010
 Why?
Recurrence
1
1999
1060
0.010
 Why?
Anti-Inflammatory Agents
1
1999
496
0.010
 Why?
Patient Selection
1
1999
696
0.010
 Why?
RNA, Antisense
1
1988
17
0.000
 Why?
DNA, Recombinant
1
1988
47
0.000
 Why?
Sequence Homology, Nucleic Acid
1
1988
155
0.000
 Why?
Aged
1
2006
23961
0.000
 Why?
Virus Replication
1
1988
483
0.000
 Why?
Middle Aged
1
2006
33479
0.000
 Why?
Cell Line
1
1988
2847
0.000
 Why?
DNA
1
1988
1459
0.000
 Why?
Abzug's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (408) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)